Abciximab Rescue in Acute Carotid Stent Thrombosis

References

1. ↵
   Topol EJ, Califf RM, Lincoff AM, et al. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators [see comments]. N Engl J Med 1997;336:1689-1696

   CrossRefPubMedWeb of Science
2. ↵
   Roubin GS, Yadav S, Iyer SS, Vitek J. Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am J Cardiol 1996;78:8-12
3. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 1996;3:42-62

   CrossRefPubMedWeb of Science
4. ↵
   Kornowski R, Hong MK, Saucedo J, et al. Procedural results and long-term clinical outcomes following coronary stenting in perimyocardial infarction syndromes. Am J Cardiol 1998;82:1163-1167

   PubMed
5. Liu MW, Voorhees WD III, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary balloon angioplasty: a Cook registry study. Am Heart J 1995;130:8-13

   CrossRefPubMedWeb of Science
6. ↵
   Jeong MH, Owen WG, Staab ME, et al. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure. Cathet Cardiovasc Diagn 1996;38:38-43

   CrossRefPubMed
7. ↵
   Makkar RR, Litvack F, Eigler NL, et al. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis. Circulation 1997;95:1015-1021

   Abstract/FREE Full Text
8. ↵
   Topol EJ, Califf RM, Smith CR, et al. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation [see comments]. N Engl J Med 1994;330:956-961

   CrossRefPubMedWeb of Science
9. ↵
   Moussa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364-2366

   Abstract/FREE Full Text
10. ↵
    Savcic M, 7Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 1999;25:15-19
11. ↵
    Rupprecht HJ, Darius H, Borkowski U, et al. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation 1998;97:1046-1052

    Abstract/FREE Full Text
12. ↵
    Rechavia E, Wurzel M. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery. Circulation 1998;98:1249-1250

    FREE Full Text
13. ↵
    Henry P, Boughalem K, Rinaldi JP, et al. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation. Cathet Cardiovasc Diagn 1998;43:105-107

    PubMed
14. ↵
    Berkompas DC. Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis. Cathet Cardiovasc Diagn 1998;45:272-274

    PubMed
15. ↵
    Bailey SR, O'Leary E, Chilton R. Angioscopic evaluation of site-specific administration of ReoPro [see comments]. Cathet Cardiovasc Diagn 1997;42:181-184

    CrossRefPubMedWeb of Science
16. ↵
    Wallace RC, Furlan AJ, Moliterno DJ, Stevens GH, Masaryk TJ, Perl J III. Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor. AJNR Am J Neuroradiol 1997;18:1257-1260

    Abstract
17. ↵
    Samuels OB, Mohammad Y, Stern BJ, et al, presented at the American Society of Interventional and Therapeutic Neuroradiology meeting, January 1999
18. ↵
    Lempert TE, Malek AM, Halbach VV, Phatouros CC, Dowd CF, Higashida RT. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke 1999;30:693-695

    FREE Full Text